Genomic Characterization of a RET Inhibitor–Resistant RET Fusion–Positive Lung Cancer by CSF Cell-Free DNA Hybrid Capture–Based Sequencing

Eitemau Tebyg

• Decade in review: a new era for RET-rearranged lung cancers
  gan: Choudhury, Noura J., et al.
  Cyhoeddwyd: (2020)
• Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
  gan: Drilon, Alexander, et al.
  Cyhoeddwyd: (2013)
• TRK inhibitors in TRK fusion-positive cancers
  gan: Drilon, A
  Cyhoeddwyd: (2019)
• A Performance Comparison of Commonly Used Assays to Detect RET Fusions
  gan: Yang, Soo-Ryum, et al.
  Cyhoeddwyd: (2020)
• Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases
  gan: Guo, Robin, et al.
  Cyhoeddwyd: (2019)